About Dana Farber Cancer Institute-Hematopoietic Stem Cell Transplant Program
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Dana Farber Cancer Institute-Hematopoietic Stem Cell Transplant Program
During the past decade, Dana Farber Cancer Institute-Hematopoietic Stem Cell Transplant Program conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Dana Farber Cancer Institute-Hematopoietic Stem Cell Transplant Program
According to Clinical.Site data, the most researched conditions in "Dana Farber Cancer Institute-Hematopoietic Stem Cell Transplant Program" are
"Acute Lymphoblastic Leukemia (ALL)" (1 trials), "Acute Myelogenous Leukemia (AML)" (1 trials), "Chronic Lymphocytic Leukemia (CLL)" (1 trials), "Hematologic Malignancies" (1 trials) and "Hodgkin's Disease" (1 trials). Many other conditions were trialed in "Dana Farber Cancer Institute-Hematopoietic Stem Cell Transplant Program" in a lesser frequency.
Clinical Trials Intervention Types at Dana Farber Cancer Institute-Hematopoietic Stem Cell Transplant Program
Most popular intervention types in "Dana Farber Cancer Institute-Hematopoietic Stem Cell Transplant Program" are "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "ProHema-CB" (1 trials), "Single FT1050 treated UCB unit" (1 trials) and "Untreated CB" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Dana Farber Cancer Institute-Hematopoietic Stem Cell Transplant Program
The vast majority of trials in "Dana Farber Cancer Institute-Hematopoietic Stem Cell Transplant Program" are
2 trials for "All" genders.
Clinical Trials Status at Dana Farber Cancer Institute-Hematopoietic Stem Cell Transplant Program
Currently, there are NaN active trials in "Dana Farber Cancer Institute-Hematopoietic Stem Cell Transplant Program".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Dana Farber Cancer Institute-Hematopoietic Stem Cell Transplant Program,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Dana Farber Cancer Institute-Hematopoietic Stem Cell Transplant Program, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".